Post by Aptar Digital Health

We’re proud to announce that the Instanyl DoseGuard Nasal Spray Device has been selected as a finalist in the Pharmapack Awards 2026 in the Delivery & Device Innovation category. Designed for precise medication delivery, Instanyl DoseGuard is an electronic nasal lockout device for precise medication delivery. Designed to manage breakthrough pain in adults on long-term cancer pain medication, it helps prevent overdose, misuse, abuse, diversion, accidental exposure, and medication errors. Join us at Pharmapack Europe in January to learn more about Aptar Pharma’s latest innovation  #DeviceInnovation #Pharmapack2026